))
E83: Altis Biosystems Innovates Predictive Drug Testing on the Human Intestine
Manage episode 382116396 series 3526088
Contenuto fornito da Venture In The South. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Venture In The South o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Existing predictive models for drug behavior in the human intestine have been hit or miss, leading to unpredicted failure of drug development at the cost of billions. Altis Biosystems has developed a proprietary intestinal model with human stem cells that dramatically improves the predictive capability of drug effects and toxicity in the intestine and thus can substantially reduce the cost of drug development failure. CEO Ben Scruggs has 16 of the top 20 Big Pharma companies as customers as the Altis human intestinal model dominates pre-clinical drug testing for intestinal effects and toxicity. (recorded 9/8/23)
Follow David on LinkedIn or reach out to David on Twitter/X @DGRollingSouth for comments.
Follow Paul on LinkedIn or reach out to Paul on Twitter/X @PalmettoAngel
We invite your feedback and suggestions at www.ventureinthesouth.com or email david@ventureinthesouth.com. Learn more about RollingSouth at rollingsouth.vc or email david@rollingsouth.vc.
Download our White Papers and Cheat Sheets HERE. Thanks for listening and remember: Our mission is to MAKE MONEY, HAVE FUN, AND DO GOOD.
130 episodi
Condividi
